Brief: Cipher Pharmaceuticals Expects Q2 2019 Earnings Per Share In Range Of $0.04 To $0.05

Cipher Pharmaceuticals

29/07/2019 14:05

July 29 (Reuters) - Cipher Pharmaceuticals Inc  CPH.TO :
    * CIPHER PHARMACEUTICALS ANNOUNCES MANAGEMENT CHANGE &
PRELIMINARY
Q2 FINANCIAL HIGHLIGHTS
    * CIPHER PHARMACEUTICALS INC - CRAIG MULL HAS BEEN NAMED
INTERIM
CHIEF EXECUTIVE OFFICER OF CIPHER, REPLACING ROBERT TESSAROLO
    * CIPHER PHARMACEUTICALS INC - CO HAS COMMENCED A FORMAL
SEARCH
PROCESS FOR A NEW CHIEF EXECUTIVE OFFICER
    * CIPHER PHARMACEUTICALS INC - EXPECTS Q2 2019EARNINGS PER
SHARE
IN RANGE OF $0.04 TO $0.05
    * CIPHER PHARMACEUTICALS INC - SEES Q2 2019 REVENUE IN RANGE
OF
$5.4 MILLION TO $5.6 MILLION, COMPARED WITH $6.95 MILLION IN Q2
2018

Source text for Eikon:  ID:nCNWKtRC3a 
Further company coverage:  CPH.TO 

 ((Reuters.Briefs@thomsonreuters.com;))